Position in TGTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$454,408
+$230,000 QoQ
Shares Held
8,271
+33.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#253
of 425 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inspire Advisors, LLC holds $5,818,365 across 11 Biotechnology names. TGTX ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
16,711 | $1,894,358 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
19,880 | $1,084,255 | |
| 3 | EXEL |
Exelixis, Inc.
|
16,370 | $890,691 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
8,271 | $454,408 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
958 | $356,059 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,788 | $282,130 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,408 | $277,786 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
8,423 | $275,600 |
All Filings in TGTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $454,408 | 8,271 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $224,408 | 6,212 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $201,651 | 5,603 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||